The 20 Best Teratocarcinosarcoma Doctors in The United States

Additional Credentials:Division Chief, Rhinology and Skull Base SurgeryUniversity of Michigan Ross School of Business, 2012. Dr. Mckean is rated as an Elite provider by MediFind in the treatment of Teratocarcinosarcoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Olfactory Neuroblastoma, Teratocarcinosarcoma, Sinus Cancer, Balloon Sinuplasty, and Turbinectomy. Dr. Mckean is board certified in Otolaryngology-Head & Neck Surgery.

I am grateful for the opportunity to listen to patients concerns and to find ways to help them achieve their personal goals. Its rewarding to learn from patients as I educate them about their health issues and offer them treatment options tailored to their specific needs. I have completed fellowship training to benefit patients with diseases of the sinus and nasal airway and collaborate with my colleagues in the Department of Neurosurgery to offer minimally invasive endoscopic approaches to lesions of the anterior skullbase. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nasal Polyps, Septoplasty, and Balloon Sinuplasty. Dr. Chan is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Chan is currently accepting new patients.

. Dr. Zajonc is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Nasal Septal Hematoma, Low Nasal Bridge, Perichondritis, and Myringotomy. Dr. Zajonc is board certified in American Board Of Otolaryngology.

. Dr. Colvett is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Laryngeal Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Colvett is board certified in American Board Of Radiology.

Sandeep Chunduri is a Hematologist and an Oncologist practicing medicine in Crystal Lake, Illinois. Dr. Chunduri is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Vaginal Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Chunduri is board certified in American Board Of Internal Medicine, Hematology.

General radiation oncology. Dr. Whipple is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma. Dr. Whipple is board certified in American Board Of Radiology. Dr. Whipple is currently accepting new patients.

Dr. Kemmis was born and raised in South Dakota. He earned a bachelor’s degree from the University of South Dakota and then continued his education at the University of South Dakota Sanford School of Medicine, where he received his medical degree. From a young age, Dr. Kemmis took interest in the practice of medicine. He found his passion in Radiation Oncology and loves the opportunity to care for cancer patients by offering advanced and rapidly progressive treatments. Dr. Kemmis’ philosophy of care is, “I enjoy engaging patient in all treatment options available for their specific disease.  I am here to educate and assist patients in making the best decision for their specific needs.” He would like for his patients to know that his goal is to help educate first and foremost, even if treatment is not chosen.Dr. Kemmis is an investigator involved in clinical research trials in the areas of breast surgery. His research includes surgical treatment of the breast. When he is not at work, Dr. Kemmis enjoys outdoor activities with his family.Dr. Kemmis is excited to provide treatment options for all types of cancer at Lutheran Medical Center. Dr. Kemmis is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Metastatic Brain Tumor, and Lung Cancer. Dr. Kemmis is board certified in American Board Of Radiology. Dr. Kemmis is currently accepting new patients.

My practice focuses on the treatment of cancer with radiation therapy. I treat cancers of all sites including brain, breast, lung, head and neck, GI organs, prostate, GYN organs, and bone/soft tissue. We use multiple modalities of treatment including IMRT, SBRT, Stereotactic radiosurgery, and brachytherapy.Dr. Spencer Ashton is a radiation oncologist at Intermountain Healthcare. He specializes in the treatment of all cancer types and is trained in multiple advanced radiation delivery techniques including intensity-modulated radiation therapy, stereotactic body radiation therapy, and high and low-dose rate brachytherapy. Dr. Ashton is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, Lung Cancer, and Familial Prostate Cancer. Dr. Ashton is board certified in American Board Of Radiology. Dr. Ashton is currently accepting new patients.

Dr. Todd Barnett is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Barnett earned his medical degree from Northwestern University, Chicago, Ill. He completed his residency and fellowship at Stanford University, Calif. Dr. Barnett is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Thyroid Cancer. Dr. Barnett is board certified in American Board Of Radiology. Dr. Barnett is currently accepting new patients.

Dr. Weintraub is originally from Canton, Connecticut. She earned a bachelor’s degree from Harvard University and continued her education at the University of Colorado School of Medicine, where she received her medical degree.Following her education, she completed her residency in Radiation Oncology at the University of Colorado Health. From an early age, Dr. Weintraub knew that she wanted a career that would allow her to help others in need. Being able to provide patients with the most advanced treatments, by utilizing cutting-edge radiology techniques, is one of her favorite aspects of working in radiation oncology.Dr. Weintraub is an investigator involved in clinical research trials in the area of radiation oncology. Her research focus includes the treatment of various cancers with radiation. Dr. Weintraub’s philosophy of care is, “My goal is to support each patient by using evidence-based medicine and each patient’s own goals to arrive at a patient-centered treatment plan.” She cares deeply about each of her patients and loves that her career allows her to provide support and guidance during their challenging health journeys. In her free time, Dr. Weintraub enjoys spending time with her family and reading. She also enjoys spending time in nature and trail running. Dr. Weintraub is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Familial Pancreatic Cancer, and Posterior Fossa Tumor. Dr. Weintraub is board certified in American Board Of Radiology. Dr. Weintraub is currently accepting new patients.

"""Dr. Oxford is board certified in Otolaryngologist who attended UT Southwestern Medical Center for medical school and his Otolaryngology residency. He then completed his Head and Neck Cancer and reconstructive surgery fellowship at the University of Michigan in Ann Arbor, MI.Dr. Oxford specializes in surgery for both benign and malignant tumors of the head and neck including the throat, face, thyroid, parathyroid, skin and parotid.""". Dr. Oxford is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Endoscopy. Dr. Oxford is board certified in Otolaryngology- American Board Of Otolaryngology - Head And Neck Surgery.

Carl H. Snyderman, MD, is a professor in the department of otolaryngology at the University of Pittsburgh School of Medicine and codirector of the UPMC Center for Skull Base Surgery. He specializes in otolaryngology-head and neck surgery, and cranial base surgery. Dr. Snyderman is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Cerebrospinal Fluid Leak, Olfactory Neuroblastoma, Sinus Cancer, Endoscopy, and Nerve Decompression. Dr. Snyderman is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Snyderman is currently accepting new patients.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, and Teratocarcinosarcoma.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy. Dr. London is board certified in Head And Neck Surgery.

Roy Tishler is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Tishler is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Teratocarcinosarcoma, Olfactory Neuroblastoma, Renal Oncocytoma, and Gastrostomy. Dr. Tishler is board certified in Radiation Oncology.

Clementino Solares is an Otolaryngologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 26 years. Dr. Solares is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Sinus Cancer, Olfactory Neuroblastoma, Tissue Biopsy, and Nerve Decompression. Dr. Solares is board certified in American Board Of Otolaryngology - Head And Neck Surgery, 2010.

Itai Pashtan is a Radiation Oncologist practicing medicine in Mansfield, Massachusetts. Dr. Pashtan is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Laryngeal Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Pashtan is board certified in Radiation Oncology.

Anthony Scarpaci is a Hematologist and an Oncologist practicing medicine in Sewell, New Jersey. Dr. Scarpaci is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Sinus Cancer, Teratocarcinosarcoma, Olfactory Neuroblastoma, and Paget Disease of the Breast. Dr. Scarpaci is board certified in Medical Oncology, Internal Medicine, and Hematology. Dr. Scarpaci is currently accepting new patients.

Paul Mitsuyama, MD, is a board-certified radiation oncologist who employs targeted radiation therapy to destroy cancer cells while preserving and maintaining the health of tissues around them. He has experience in both high- and low-dose-rate brachytherapy for gynecologic malignancies and prostate cancer, respectively. He also has expertise in intensity-modulated radiation therapy and three-dimensional conformal radiation therapy for a variety of conditions including head and neck cancers, brain tumors, lung cancer and gastrointestinal diseases such as colorectal cancer.Dr. Mitsuyama is a strong believer in patient education. He is committed to ensuring all of his patients fully understand their diagnosis, as well as the reason for receiving radiation therapy. He is also highly focused on patient safety and enjoys the opportunity to help people that his role as a radiation oncologist provides.Away from work, Dr. Mitsuyama enjoys spending time with his family, including his adopted animals. He likes to cycle, play tennis and snowboard in his free time. Dr. Mitsuyama is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Teratocarcinosarcoma, Sinus Cancer, Olfactory Neuroblastoma, and Familial Prostate Cancer. Dr. Mitsuyama is board certified in American Board Of Radiology. Dr. Mitsuyama is currently accepting new patients.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy. Dr. Frank is board certified in American Board Of Otolaryngology.